GH1 and chronic kidney disease: However, most studies have used dual energy X-ray absorptiometry (DXA) to measure muscle mass as a surrogate marker for the effect of GH treatment in hemodialysis patients, but the validity of this extrapolation in CKD is questionable since DXA cannot differentiate between a true increase in muscle mass versus fluid overload [11].